Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Sonoma Pharmaceuticals (SNOA) Net Income (2016 - 2025)

Sonoma Pharmaceuticals has reported Net Income over the past 15 years, most recently at -$819000.0 for Q4 2025.

For Q4 2025, Net Income rose 11.75% year-over-year to -$819000.0; the TTM value through Dec 2025 reached -$3.4 million, up 10.09%, while the annual FY2025 figure was -$3.5 million, 28.5% up from the prior year.
Net Income for Q4 2025 was -$819000.0 at Sonoma Pharmaceuticals, down from -$534000.0 in the prior quarter.
Over five years, Net Income peaked at -$534000.0 in Q3 2025 and troughed at -$1.9 million in Q4 2022.
A 4-year average of -$1.1 million and a median of -$1.0 million in 2022 define the central range for Net Income.
Biggest five-year swings in Net Income: plummeted 59.86% in 2023 and later skyrocketed 58.89% in 2024.
Year by year, Net Income stood at -$1.9 million in 2022, then soared by 55.34% to -$866000.0 in 2023, then dropped by 7.16% to -$928000.0 in 2024, then grew by 11.75% to -$819000.0 in 2025.
Business Quant data shows Net Income for SNOA at -$819000.0 in Q4 2025, -$534000.0 in Q3 2025, and -$1.2 million in Q2 2025.